20 abril 2015
Early data in a preliminary human study show that an experimental immune system drug is generally safe and well tolerated in women with metastatic, triple-negative breast cancer, a persistently difficult form of the disease to treat.
http://feeds.sciencedaily.com/~r/sciencedaily/~3/iiQMVpugofA/150420085118.htm
